Hormone Replacement Therapy Market Analysis

Hormone Replacement Therapy Market Analysis

To get key market trends

  Download Free Sample

Based on product, the hormone replacement therapy market is segmented into estrogen & progesterone replacement therapy, thyroid replacement therapy, growth hormone replacement therapy, parathyroid hormone replacement therapy, and testosterone replacement therapy. The estrogen & progesterone replacement therapy held over USD 11.9 million in 2022. They are primarily used to manage the symptoms of menopause, such as hot flashes, night sweats, and mood changes. Estrogen replacement therapy also helps in preventing osteoporosis. Progesterone is usually combined with estrogen therapy to protect the uterine lining in women. Due to the increasing number of women reaching menopause and increasing awareness about menopause related symptoms are greatly impacting the progression of this segment.
 

Based on route of administration, the hormone replacement therapy market is classified into oral, parenteral, and other routes of administration. In 2022, the oral segment held majority of industry share of 41.5% and is expected to reach USD 16.9 billion by 2032. The HRT products are most commonly available in the form of pills and tablets. The patient preference, ease of administration, widespread availability, cost-effectiveness, and increased patient compliance.. Few of the most widely available parenteral delivery systems are Norditropin FlexPro Pen, Genotropin Mixer Pen, and Humatrope HumatroPen.
 

Based on disease type, the hormone replacement therapy market is segmented into menopause, growth hormone deficiency, male hypogonadism, hypothyroidism, hypoparathyroidism, and other disease types. The menopause segment is expected to grow at CAGR of 6.5% by 2032 due to the increasing geriatric population which increases the number of women suffering from menopause and the rising awareness of post-menopause issues. Because of the decline in estrogen levels during menopause leads to discomforting symptoms such as hot flashes, night sweats, mood changes, sleep disturbances, and vaginal dryness. Hormone replacement therapy is primarily used to alleviate the symptoms associated with menopause and improves the quality of life.
 

Based on the distribution channel, the hormone replacement therapy market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. In 2022, the hospital pharmacies segment held highest industry share of 50.7%. The hospital pharmacies are the primary source of prescription drugs for patients who are hospitalized or receiving other medical treatments. They have access to a wide range of hormone replacement therapy drugs. In addition to this the increasing prevalence of hormonal diseases, increasing awareness of post-menopause symptoms, and increasing prescription rate of HRT products. The retail pharmacies accounted for second highest industry share in 2022 due to the increasing adoption and availability of over-the-counter HRT products.
 

The market in North America dominated the hormone replacement therapy market in 2022 with industry share of 40.2%. The rising prevalence of menopause and growth hormone deficiency disorders, increasing awareness related to post-menopause issues, presence of key players in the industry, research and development of products with novel formulations, and increased adoption of hormone replacement therapies. Asia Pacific is expected to grow at fastest CAGR of 6.7% by 2032 due to increasing awareness related to hormonal disorders, development of novel formulations, and increasing ageing population.